The Effects of Apigenin in the Treatment of Diabetic Nephropathy: A Systematic Review of Non-clinical Studies

T Majid Muhammed, A Turki Jalil… - Mini Reviews in …, 2024 - ingentaconnect.com
Purpose: Diabetes is one of the important and growing diseases in the world. Among the
most common diabetic complications are renal adverse effects. The use of apigenin may …

Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney

WX Tang, WH Wu, XX Zeng, H Bo, SM Huang - Endocrine, 2012 - Springer
Diabetic nephropathy (DN) is a serious complication of diabetes with a poorly defined
etiology and limited treatment options. Early intervention is key to preventing the progression …

JNK signalling in human and experimental renal ischaemia/reperfusion injury

J Kanellis, FY Ma… - Nephrology Dialysis …, 2010 - academic.oup.com
Abstract Background. Ischaemia/reperfusion (I/R) is an important factor in delayed graft
function in renal transplantation and is a determinant of long-term graft outcome. This study …

[HTML][HTML] c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease

AO Smith, JA Jonassen, KM Preval, RJ Davis… - PLoS …, 2021 - journals.plos.org
Polycystic kidney disease is an inherited degenerative disease in which the uriniferous
tubules are replaced by expanding fluid-filled cysts that ultimately destroy organ function …

Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy

S Chen, C Dong, X Qian, S Huang, Y Feng, X Ye… - Journal of Diabetes and …, 2017 - Elsevier
Abstract Aims Long noncoding RNAs (lncRNAs) are implicated in various biological
processes and human diseases. Diabetic nephropathy (DN) is the leading cause of end …

[HTML][HTML] Peroxiredoxin 6 overexpression attenuates lipopolysaccharide-induced acute kidney injury

DH Lee, JH Park, SB Han, YY Jung, JT Hong - Oncotarget, 2017 - ncbi.nlm.nih.gov
Abstract Peroxiredoxin 6 (PRDX6) is a member of the PRDX family of antioxidant enzymes
and correlated with inflammatory response. Therefore, we investigated the role of PRDX6 …

Vitamin D in chronic kidney disease: new potential for intervention

K Mirkovic, J van den Born, G Navis… - Current drug …, 2011 - ingentaconnect.com
Prevention of progressive renal function loss and its complications remains the main
challenge in clinical nephrology. Although current therapeutic strategies aiming at reduction …

[HTML][HTML] SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy

H Zhang, X Liu, S Zhou, Y Jia, Y Li… - Journal of …, 2018 - jme.bioscientifica.com
c-Jun N-terminal kinase (JNK) contributes to the pathogenesis of diabetic nephropathy (DN).
The JNK inhibitor SP600125 was reported to ameliorate DN. However, the mechanism …

[HTML][HTML] DUSP6 protects murine podocytes from high glucose‑induced inflammation and apoptosis

L Chen, Y Wang, H Luan, G Ma… - Molecular …, 2020 - spandidos-publications.com
Diabetic nephropathy (DN) is one of the most severe complications that can occur in patients
with diabetes, and without effective and timely therapeutic intervention, can gradually …

Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats

AKH Lim, FY Ma, DJ Nikolic-Paterson, E Ozols… - American journal of …, 2011 - karger.com
Background/Aims: The c-Jun amino-terminal kinase (JNK) signaling pathway is activated in
human kidney diseases and promotes renal injury in experimental glomerulonephritis. In …